Balance Sheet

1.1T

Assets

716.4B

Liabilities

343.6B

Equity

Current Assets	264.2B
Cash & Short-Term Investments	42.8B
Receivables	97.3B
Other Current Assets	124.1B
Non-Current Assets	795.8B
Long-Term Investments	161B
PP&E	59B
Intangibles	554.8B
Other Non-Current Assets	21B

Current Liabilities	421.2B
Accounts Payable	50.4B
Other Current Liabilities	370.8B
Non-Current Liabilities	295.3B
Long-Term Debt	184.3B
Other Non-Current Liabilities	111B

Currency: JPY

	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023
Assets
Cash & Cash Equivalents	22 746	30 553	54 922	105 603	147 775	137 296	101 708	193 698	202 984	143 478
Cash Equivalents	22 746	30 553	54 922	105 603	147 775	137 296	101 708	193 698	202 984	143 478
Short-Term Investments	81 952	111 293	81 039	17 494	22 066	43 750	28 717	29 480	35 596	20 174
Total Receivables	153 262	151 999	155 587	118 966	113 401	119 243	140 368	136 060	151 500	98 630
Accounts Receivables	111 542	102 947	107 161	110 700	110 582	116 059	129 368	128 569	141 020	86 405
Other Receivables	41 720	49 052	48 426	8 266	2 819	3 184	11 000	7 491	10 480	12 225
Inventory	59 141	62 387	59 587	60 286	60 169	66 889	79 368	92 215	99 021	94 405
Other Current Assets	42 510	45 467	70 449	5 211	5 170	6 090	13 929	8 342	10 420	25 173
Total Current Assets	359 611	401 699	421 584	307 560	348 581	373 268	364 090	459 795	499 521	381 860
PP&E Net	72 689	65 160	61 824	61 121	58 204	59 485	65 748	64 966	64 091	58 909
PP&E Gross	72 689	65 160	61 824	61 121	58 204	59 485	65 748	64 966	64 091	58 909
Accumulated Depreciation	149 342	148 272	154 453	159 828	161 841	157 542	129 214	122 819	132 888	130 474
Intangible Assets	76 127	85 788	79 630	197 114	189 681	171 390	421 029	383 406	398 692	329 314
Goodwill	80 669	88 075	76 950	100 194	95 097	99 348	173 464	176 492	195 144	209 415
Note Receivable	0	0	0	0	2 453	2 562	0	6 726	5 538	6 042
Long-Term Investments	50 823	58 193	60 432	52 681	70 993	74 668	200 923	193 035	115 844	134 007
Other Long-Term Assets	19 113	12 668	7 295	60 402	44 675	53 996	31 280	23 707	29 177	15 195
Other Assets	80 669	88 075	76 950	100 194	95 097	99 348	173 464	176 492	195 144	209 415
Total Assets	659 032 N/A	711 583 +8%	707 715 -1%	779 072 +10%	809 684 +4%	834 717 +3%	1 256 534 +51%	1 308 127 +4%	1 308 007 0%	1 134 742 -13%
Liabilities
Accounts Payable	11 713	12 492	12 153	14 514	17 512	15 498	25 640	26 076	22 455	13 403
Accrued Liabilities	7 786	0	10 809	0	0	0	0	0	0	0
Short-Term Debt	0	0	1 010	40 000	3 500	0	270 000	5 000	5 025	90 588
Current Portion of Long-Term Debt	10 000	36 522	22 000	18 000	12 960	3 697	9 097	11 019	25 832	4 871
Other Current Liabilities	101 708	98 413	133 750	159 619	176 276	178 979	191 761	236 052	225 061	263 832
Total Current Liabilities	131 207	156 843	179 722	232 133	210 248	198 174	496 498	278 147	278 373	372 694
Long-Term Debt	85 000	50 000	28 000	10 000	30 940	29 286	37 745	275 526	254 510	251 788
Deferred Income Tax	15 704	15 704	16 209	72	95	0	26 768	28 424	26 550	36 505
Minority Interest	0	0	0	0	0	0	103 190	67 608	65 681	33
Other Liabilities	28 581	36 365	37 312	124 599	115 678	109 119	59 663	77 852	75 005	66 973
Total Liabilities	260 492 N/A	260 562 +0%	261 243 +0%	366 804 +40%	356 961 -3%	336 579 -6%	723 864 +115%	727 557 +1%	700 119 -4%	727 993 +4%
Equity
Common Stock	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400	22 400
Retained Earnings	318 861	326 686	341 401	357 769	396 037	431 799	457 330	508 677	514 210	280 999
Additional Paid In Capital	15 860	15 860	15 860	15 860	15 860	15 861	17 837	15 855	16 725	0
Unrealized Security Profit/Loss	17 247	17 247	0	0	31 735	32 611	46 118	38 575	23 838	39 260
Treasury Stock	656	660	0	667	669	674	677	679	681	682
Other Equity	24 828	63 636	42 181	16 906	12 640	3 859	10 338	4 258	31 396	64 772
Total Equity	398 540 N/A	451 021 +13%	446 472 -1%	412 268 -8%	452 723 +10%	498 138 +10%	532 670 +7%	580 570 +9%	607 888 +5%	406 749 -33%
Total Liabilities & Equity	659 032 N/A	711 583 +8%	707 715 -1%	779 072 +10%	809 684 +4%	834 717 +3%	1 256 534 +51%	1 308 127 +4%	1 308 007 0%	1 134 742 -13%
Shares Outstanding
Common Shares Outstanding	397	397	397	397	397	397	397	397	397	397

Income Statement Balance Sheet Cash Flow Statement

Sumitomo Pharma Co Ltd
TSE:4506

Balance Sheet

Balance Sheet Decomposition
Sumitomo Pharma Co Ltd

Balance Sheet
Sumitomo Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Sumitomo Pharma Co Ltd TSE:4506

Balance Sheet

Balance Sheet Decomposition Sumitomo Pharma Co Ltd

Balance Sheet Sumitomo Pharma Co Ltd

See Also

Company

Help

Tools

Stocks

Sumitomo Pharma Co Ltd
TSE:4506

Balance Sheet Decomposition
Sumitomo Pharma Co Ltd

Balance Sheet
Sumitomo Pharma Co Ltd